Study Stopped
not enough subjects recruited
Sponsor study identifier
observational
1
1 country
1
Study Start
March 6, 2013
Actual (reported)Primary Completion
March 6, 2013
Actual (reported)Study Completion
March 6, 2013
Actual (reported)The prevalence of diabetes is increasing and the management of the disease is nowadays considered a major challenge. Affected patients have increased mortality and morbidity as well as a significant drop in the quality of life. The complications of diabetes can be classified as microvascular (e.g. nephropathy, neuropathy or retinopathy) or macrovascular (e.g. cardiovascular or cerebrovascular). Several large-scale epidemiologic studies indicating that wider retinal venous caliber is strongly associated with the fasting glucose level as well as with diabetes. Another retinal vascular abnormality that is associated with diabetes is an abnormal retinal vascular response to flicker stimulation. Retinal vessel dilatation in response to stimulation with diffuse flicker light occurs due to a phenomenon called neurovascular coupling. This means that increased activity of neurons is associated with an increased retinal metabolism. This leads to a release of endogenous vasodilator substances and increased blood flow. However, previous studies were limited by the fact that retinal vessel diameters and blood flow were not measured simultaneously. The present study aims to investigate whether the response of retinal vessel diameters and blood flow velocities to flicker stimulation is altered in patients with diabetes. Both parameters will be measured in real time using Fourier Domain Doppler OCT.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 6, 2013
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 11, 2011
Actual (reported)June 17, 2011
Actual (reported)March 6, 2013
Actual (reported)March 6, 2013
Actual (reported)March 6, 2013
Actual (reported)Retinal vessel diameters
18 months
Retinal blood flow velocities
18 months
Patients with early insulin dependent diabetes and no or mild non-proliferative retinopathy
healthy control subjects
24 patients with early insulin dependent diabetes and no or mild non-proliferative retinopathy, non-smokers 24 age and sex matched healthy controls, non-smokers
Department of Clinical Pharmacology
Vienna, 1090, Austria
Gerhard Garhöfer, MD
Department of Clinical Pharmacology, Medical University of Vienna
1 participants (actual enrollment reported by the registry).
First Submitted
April 11, 2011
First Posted
June 17, 2011
Study Start
March 6, 2013
Actual (reported)Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
Contact the study team to confirm eligibility.
Primary Completion
March 6, 2013
Actual (reported)Study Completion
March 6, 2013
Actual (reported)Last Updated
February 20, 2020
Record last verified: 2020-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: